Endocrine and metabolic Flashcards
Conditions and presentations
What is the minimum HbA1c that would be diagnostic of type 2 diabetes mellitus?
6.5%
48 mmol/mol
Primary hyperparathyroidism
PTH (Elevated)
Ca2+ (Elevated)
Phosphate (Low)
Urine calcium : creatinine clearance ratio > 0.01
May be asymptomatic if mild
Recurrent abdominal pain (pancreatitis, renal colic)
Changes to emotional or cognitive state
Most cases due to solitary adenoma (80%), multifocal disease occurs in 10-15% and parathyroid carcinoma in 1% or less
Secondary hyperparathyroidism
PTH (Elevated)
Ca2+ (Low or normal)
Phosphate (Elevated)
Vitamin D levels (Low)
May have few symptoms
Eventually may develop bone disease, osteitis fibrosa cystica and soft tissue calcifications
Parathyroid gland hyperplasia occurs as a result of low calcium, almost always in a setting of chronic renal failure
Tertiary hyperparathyroidism
Ca2+ (Normal or high)
PTH (Elevated)
Phosphate levels (Decreased or Normal)
Vitamin D (Normal or decreased)
Alkaline phosphatase (Elevated) Metastatic calcification
Bone pain and / or fracture
Nephrolithiasis
Pancreatitis
Occurs as a result of ongoing hyperplasia of the parathyroid glands after correction of underlying renal disorder, hyperplasia of all 4 glands is usually the cause
Treatment of primary hyperparathyroidism
Indications for surgery
* Elevated serum Calcium > 1mg/dL above normal
* Hypercalciuria > 400mg/day
* Creatinine clearance < 30% compared with normal
———————————————————————————————-
Episode of life threatening hypercalcaemia
Nephrolithiasis
Age < 50 years
Neuromuscular symptoms
Reduction in bone mineral density of the femoral neck, lumbar spine, or distal radius of more than 2.5 standard deviations below peak bone mass (T score lower than -2.5)
Secondary hyperparathyroidism management
Usually managed with medical therapy.
Indications for surgery in secondary (renal) hyperparathyroidism:
- Bone pain
- Persistent pruritus
- Soft tissue calcifications
Tertiary hyperparathyroidism management
- Allow 12 months to elapse following transplant as many cases will resolve
- The presence of an autonomously functioning parathyroid gland may require surgery.
- If the culprit gland can be identified then it should be excised.
- Otherwise total parathyroidectomy and re-implantation of part of the gland may be required.
Primary amenorrhoea
Failure to establish menstruation by 15 in girls
Normal secondary sexual characteristics
such as breast development
Or
Age of 13 girls with no secondary sexual characteristics
Secondary amenorrhoea
Cessation of menstruation for 3-6 months in women with prev normal and regular menses
6-12 months in women with previous oligomenorrhoea
Primary causes of Amenorrhoea
gonadal dysgenesis (e.g. Turner’s syndrome) - the most common causes
testicular feminisation
congenital malformations of the genital tract
functional hypothalamic amenorrhoea (e.g. secondary to anorexia)
congenital adrenal hyperplasia
imperforate hymen
Secondary causes of amenorrhoea
hypothalamic amenorrhoea (e.g. secondary stress, excessive exercise)
polycystic ovarian syndrome (PCOS)
hyperprolactinaemia
premature ovarian failure
thyrotoxicosis (hypothyroidism)
Sheehan’s syndrome
Asherman’s syndrome (intrauterine adhesions)
Pregnancy
Investigations for amenorrhoea
exclude pregnancy with urinary or serum bHCG
full blood count, urea & electrolytes, coeliac screen, thyroid function tests
gonadotrophins
low levels indicate a hypothalamic cause where as raised levels suggest an ovarian problem (e.g. Premature ovarian failure)
raised if gonadal dysgenesis (e.g. Turner’s syndrome)
prolactin
androgen levels
raised levels may be seen in PCOS
oestradiol
Management of primary amenorrhoea
investigate and treat any underlying cause
with primary ovarian insufficiency due to gonadal dysgenesis (e.g. Turner’s syndrome) are likely to benefit from hormone replacement therapy (e.g. to prevent osteoporosis etC)
Secondary amenorrhoea
exclude pregnancy, lactation, and menopause (in women 40 years of age or older)
treat the underlying cause
What is ectopic pregnancy?
Implantation of a fertilized ovum outside the uterus results in an ectopic pregnancy
27 year old woman who presents to the emergency department with a history female with a history of 6-8 weeks amenorrhoea who presents with lower abdominal pain and later develops vaginal bleeding
Ectopic pregnancy
Ectopic pregnancy symptoms
lower abdominal pain
due to tubal spasm
typically the first symptom
pain is usually constant and may be unilateral.
vaginal bleeding
usually less than a normal period
may be dark brown in colour
history of recent amenorrhoea
typically 6-8 weeks from the start of last period
if longer (e.g. 10 wks) this suggest another causes e.g. inevitable abortion
peritoneal bleeding can cause shoulder tip pain and pain on defecation / urination
dizziness, fainting or syncope may be seen
symptoms of pregnancy such as breast tenderness may also be reported
Signs of ectopic pregnancy
abdominal tenderness
cervical excitation (also known as cervical motion tenderness)
adnexal mass: NICE advise NOT to examine for an adnexal mass due to an increased risk of rupturing the pregnancy. A pelvic examination to check for cervical excitation is however recommended
Pregnancy of unknown location investigation
case of pregnancy of unknown location, serum bHCG levels >1,500 points toward a diagnosis of an ectopic pregnancy
Osteomalacia
softening of the bones secondary to low vitamin D levels that in turn lead to decreased bone mineral content. If this occurs in growing children it is referred to as rickets, with the term osteomalacia preferred for adults.
Causes of osteomalacia
vitamin D deficiency
malabsorption
lack of sunlight
diet
chronic kidney disease
drug induced e.g. anticonvulsants
inherited: hypophosphatemic rickets (previously called vitamin D-resistant rickets)
liver disease: e.g. cirrhosis
coeliac disease
Features of Osteomalacia
bone pain
bone/muscle tenderness
fractures: especially femoral neck
proximal myopathy: may lead to a waddling gait
Investigations of osteomalacia
bloods
low vitamin D levels
low calcium, phosphate (in around 30%)
raised alkaline phosphatase (in 95-100% of patients)
x-ray
translucent bands (Looser’s zones or pseudofractures)
Treatment of osteomalacia
- vitamin D supplementation
A loading dose is often needed initially
calcium supplementation if dietary calcium is inadequate
Paget’s disease of the bone
primarily a disorder of osteoclasts, with excessive osteoclastic resorption followed by increased osteoblastic activity. Paget’s disease is common (UK prevalence 5%) but symptomatic in only 1 in 20 patients.
Which bones are commonly affected by Paget’s disease?
The skull, spine/pelvis, and long bones of the lower extremities are most commonly affected.
Predisposing factors for Paget’s’s disease
increasing age
male sex
northern latitude
family history
Clinical features of Paget’s disease?
only 5% of patients are symptomatic
the stereotypical presentation is an older male with bone pain and an isolated raised ALP
bone pain (e.g. pelvis, lumbar spine, femur)
classical, untreated features: bowing of tibia, bossing of skull
Investigations for Paget’s disease
- bloods
- other markers of bone turnover
- X-rays
- bone scintigraphy
Paget’s disease blood findings
raised alkaline phosphatase (ALP)
calcium and phosphate are typically normal. Hypercalcaemia may occasionally occur with prolonged immobilisation
Other markers of bone turnover in Paget’s disease
procollagen type I N-terminal propeptide (PINP)
serum C-telopeptide (CTx)
urinary N-telopeptide (NTx)
urinary hydroxyproline
X-rays Paget’s disease
osteolysis in early disease → mixed lytic/sclerotic lesions later
skull x-ray: thickened vault, osteoporosis circumscripta
Bone scintigraphy Paget’s disease
Increased uptake is seen focally at the sites of active bone lesion
Management of Paget’s disease
indications for treatment include
bone pain
skull or long bone deformity
fracture
periarticular Paget’s
bisphosphonate (either oral risedronate or IV zoledronate)
calcitonin is less commonly used now
Complications of bone disease
deafness (cranial nerve entrapment)
bone sarcoma (1% if affected for > 10 years)
fractures
skull thickening
high-output cardiac failure
Primary hyperparathyroidism
excess secretion of PTH resulting in hypercalcaemia. It is the most common cause of hypercalcaemia in outpatients and is often diagnosed following an incidental finding of an elevated serum calcium concentration.
In 85% of cases a parathyroid adenoma is responsible.
Causes of primary hyperparathyroidism
85%: solitary adenoma
10%: hyperplasia
4%: multiple adenoma
1%: carcinoma
Symptomatic features of primary hyperparathyroidism
- 80% of patients may asymptomatic
polydipsia, polyuria
depression
anorexia, nausea, constipation
peptic ulceration
pancreatitis
bone pain/fracture
renal stones
hypertension
Primary hyperparathyroidism mnemonic
`Bones, groans, abdominal groans and psychic moans
Associations of primary hyperparathyroidism
- hypertension
- mutiple endocrine neoplasia: Men I and Men II
Treatment of primary hyperparathyroidism
the definitive management is total parathyroidectomy
conservative management may be offered if the calcium level is less than 0.25 mmol/L above the upper limit of normal AND the patient is > 50 years AND there is no evidence of end-organ damage
patients not suitable for surgery may be treated with cinacalcet, a calcimimetic
a calcimimetic ‘mimics’ the action of calcium on tissues by allosteric activation of the calcium-sensing receptor
Investigations of primary hyperparathyroidism
bloods
raised calcium, low phosphate
PTH may be raised or (inappropriately, given the raised calcium) normal
technetium-MIBI subtraction scan
x-ray findings
pepperpot skull
osteitis fibrosa cystica
Gynaecomastia
abnormal amount of breast tissue in males and is usually caused by an increased oestrogen:androgen ratio. It is important to differentiate the causes of galactorrhoea (due to the actions of prolactin on breast tissue) from those of gynaecomastia
Causes of gynaecomastia
physiological: normal in puberty
syndromes with androgen deficiency: Kallman’s, Klinefelter’s
testicular failure: e.g. mumps
liver disease
testicular cancer e.g. seminoma secreting hCG
ectopic tumour secretion
hyperthyroidism
haemodialysis
drugs: see below
Drugs which cause gynaecomastia
spironolactone (most common drug cause)
cimetidine
digoxin
cannabis
finasteride
GnRH agonists e.g. goserelin, buserelin
oestrogens, anabolic steroids
Very rare drugs which cause gynaecomastia
tricyclics
isoniazid
calcium channel blockers
heroin
busulfan
methyldopa
Hypertension
a clinic reading persistently above >= 140/90 mmHg, or:
a 24 hour blood pressure average reading >= 135/85 mmHg
Primary hypertension
This is where there is no single disease causing the rise in blood pressure but rather a series of complex physiological changes which occur as we get older.
Secondary hypertension
caused by a wide variety of endocrine, renal and other causes.
Renal disease secondary hypertension
Glomerulonephritis
• Chronic pyelonephritis
• Adult polycystic kidney disease
• Renal artery stenosis
Endocrine disorders secondary hypertension
Primary hyperaldosteronism
• Phaeochromocytoma
• Cushing’s syndrome
• Liddle’s syndrome
• Congenital adrenal hyperplasia (11-beta hydroxylase deficiency)
• Acromegaly
Other causes of Secondary hypertension
Glucocorticoids
• NSAIDs
• Pregnancy
• Coarctation of the aorta
• Combined oral contraceptive pill
Signs and symptoms of hypertension
Typically asymptomatic
If above 200/120 patients may experience
headaches
visual disturbance
seizures
What else to check when suspecting hypertension
fundoscopy: to check for hypertensive retinopathy
urine dipstick: to check for renal disease, either as a cause or consequence of hypertension
ECG: to check for left ventricular hypertrophy or ischaemic heart disease
Investigation of 24hr blood pressure
- 24 hour reasoning
-24 hour blood pressure monitoring is not available then home readings using an automated sphygmomanometer are useful.
urea and electrolytes: check for renal disease, either as a cause or consequence of hypertension
HbA1c: check for co-existing diabetes mellitus, another important risk factor for cardiovascular disease
lipids: check for hyperlipidaemia, again another important risk factor for cardiovascular disease
ECG
urine dipstick
Management of hypertension
drug therapy using antihypertensives
modification of other risk factors to reduce the overall risk of cardiovascular disease
monitoring the patient for the development of complications of hypertension
Angiotensin-converting enzyme (ACE) inhibitor
Inhibit the conversion angiotensin I to angiotensin II
Associated with cough, angioedema, hyperkalaemia
Calcium channel blockers
Block voltage-gated calcium channels relaxing vascular smooth muscle and force of myocardial contraction
Flushing
Ankle swelling
Headache
Thiazide type diuretics
Inhibit sodium absorption at the beginning of the distal convoluted tubule
Hyponatraemia
Hypokalaemia
Dehydration
Angiotensin II receptor blockers (A2RB)
Block effects of angiotensin II at the AT1 receptor
Hyperkalaemia
Stage 1 hypertension
Clinic BP >= 140/90 mmHg and subsequent ABPM daytime average or HBPM average BP >= 135/85 mmHg
Stage 2 hypertension
Clinic BP >= 160/100 mmHg and subsequent ABPM daytime average or HBPM average BP >= 150/95 mmHg
Severe hypertension
Clinic systolic BP >= 180 mmHg, or clinic diastolic BP >= 120 mmHg
the blood pressure is >= 180/120 mmHg:
admit for specialist assessment if:
signs of retinal haemorrhage or papilloedema (accelerated hypertension) or
life-threatening symptoms such as new-onset confusion, chest pain, signs of heart failure, or acute kidney injury
NICE also recommend referral if a phaeochromocytoma is suspected (labile or postural hypotension, headache, palpitations, pallor and diaphoresis)
if none of the above then arrange urgent investigations for end-organ damage (e.g. bloods, urine ACR, ECG)
if target organ damage is identified, consider starting antihypertensive drug treatment immediately, without waiting for the results of ABPM or HBPM.
if no target organ damage is identified, repeat clinic blood pressure measurement within 7 days
Amubulatory blood pressure
at least 2 measurements per hour during the person’s usual waking hours (for example, between 08:00 and 22:00)
use the average value of at least 14 measurements
If ABPM not tolerated, consider HBPM
HBPM
for each BP recording, two consecutive measurements need to be taken, at least 1 minute apart and with the person seated
BP should be recorded twice daily, ideally in the morning and evening
BP should be recorded for at least 4 days, ideally for 7 days
discard the measurements taken on the first day and use the average value of all the remaining measurements
ABPM/HBPM >= 135/85 mmHg (i.e. stage 1 hypertension)
treat if < 80 years of age AND any of the following apply; target organ damage, established cardiovascular disease, renal disease, diabetes or a 10-year cardiovascular risk equivalent to 10% or greater
in 2019, NICE made a further recommendation, suggesting that we should ‘consider antihypertensive drug treatment in addition to lifestyle advice for adults aged under 60 with stage 1 hypertension and an estimated 10-year risk below 10%. ‘. This seems to be due to evidence that QRISK may underestimate the lifetime probability of developing cardiovascular disease
ABPM/HBPM >= 150/95 mmHg (i.e. stage 2 hypertension)
OFFER DRUG REGARDLESS OF AGE
Mittelschmerz
translates to ‘middle pain’ and refers to abdominal pain associated with ovulation. This mid-cyclical pain is experienced by 20% of women and there are several theories as to why it occurs
occurs due to a leakage of follicular fluid containing prostaglandins at the time of ovulation, which causes the pain. Another explanation is that the growth of the follicle stretches the surface of the ovary, causing pain.
Presentation of Mittelschmerz
Sudden onset of pain in either iliac fossa which then manifests as a generalised pelvic pain.
Typically, the pain is not severe and varies in duration, lasting from minutes to hours.
It is self-limiting and resolves within 24 hours of onset.
Pain may switch side from month to month, depending on the site of ovulation
Investigation of Mittelschmerz
There is no specific test to confirm Mittelschmerz and it diagnosed clinically, after taking a full history and examination to exclude other conditions
No abnormal signs on abdominal or pelvic examination.
Management of Mittelschmerz
Mittelschmerz is not harmful and can be controlled with simple analgesia.
Dysmenorrhoea
excessive pain during the menstrual period. It is traditionally divided into primary and secondary dysmenorrhoea.
Primary dysmenorrhoea
underlying pelvic pathology. It affects up to 50% of menstruating women and usually appears within 1-2 years of the menarche. Excessive endometrial prostaglandin production is thought to be partially responsible.
Features of primary dysmenorrhea
pain typically starts just before or within a few hours of the period starting
suprapubic cramping pains which may radiate to the back or down the thigh
Management of primary dysmenorrhea
NSAIDs such as mefenamic acid and ibuprofen are effective in up to 80% of women. They work by inhibiting prostaglandin production
combined oral contraceptive pills are used second line
Secondary dysmenorrhea
develops many years after the menarche and is the result of an underlying pathology. In contrast to primary dysmenorrhoea the pain usually starts 3-4 days before the onset of the period.
Causes of secondary dysmenorrhea
endometriosis
adenomyosis
pelvic inflammatory disease
intrauterine devices- copper coil
fibroids